Europe More Skeptical of ADHD Diagnosis, Drugs

Europe More Skeptical of ADHD Diagnosis, Drugs Play

Oct. 11 (Bloomberg) -- Bloomberg’s Trista Kelley reports on differences between the general public in Europe and the U.S. when it comes to ADHD, and what that means for pharmaceutical companies. She speaks on Bloomberg Television’s “On The Move.” (Source: Bloomberg)

  • On Air Now

    In The Loop with Betty Liu Watch Now

  • Next

    Market Makers

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus